Male breast cancer is rare in the general population with a lifetime risk of 0.1%, although the risk is significantly increased to 7-8% with BRCA2 mutation and 1% with a BRCA1 mutation [3, 4]. This evidence concerns the gene BRCA1 and breast carcinoma.